For those with lung disease, such as chronic obstructive pulmonary disease (COPD) or asthma, and for those who smoke or vape, the consequences are especially concerning. Fortunately, you can improve ...

Protein-calorie malnutrition in patients with COPD exacerbation is linked to higher risk for mortality, AKI, respiratory ...

For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit ...

Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...

SGLT2 inhibitors and GLP-1 receptor agonists were associated with fewer exacerbations of COPD in adults with type 2 diabetes. There was little difference between SGLT2 inhibitors and GLP-1 receptor ...

In bronchiectasis, highly symptomatic patients have a greater risk of exacerbations and may benefit from long-term macrolide treatment.

In a 24-week post hoc ENHANCE analysis, ensifentrine improved symptoms, dyspnea, and quality of life for stable COPD patients ...

Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...

New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.